Prentice Wealth Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-12
Closed -$4K 161
2021
Q3
$4K Hold
12
﹤0.01% 284
2021
Q2
$5K Hold
12
﹤0.01% 268
2021
Q1
$4K Buy
+12
New +$3.86K ﹤0.01% 281

Other funds holding ELV

Prentice Wealth Management's ELV Position: Q4 2021 in Review

Prentice Wealth Management sold out of Elevance Health (ELV) in Q4 2021, closing a stake of 12 shares — an estimated $4K sold.

Prentice Wealth Management first reported a position in ELV in Q1 2021 and held it in 3 quarters. The position peaked at $5K in Q2 2021. 1,372 funds tracked by Wall St. Rank hold ELV as of Q4 2021.

  • Prentice Wealth Management reported no remaining Elevance Health position as of Q4 2021 after selling out during the quarter.
  • Prentice Wealth Management sold 12 Elevance Health shares in Q4 2021, an estimated $4K.
  • Prentice Wealth Management first reported a position in Elevance Health in Q1 2021 and held it in 3 quarters.
  • Prentice Wealth Management's Elevance Health position peaked at $5K in Q2 2021.
  • 1,372 funds tracked by Wall St. Rank held Elevance Health as of Q4 2021.

Based on Prentice Wealth Management's 13F filing for Q4 2021, filed 31 Oct 2022.